Approval · Notice of Compliance 22932 · 2019
FLUCELVAX QUAD: Notice of Compliance 22932
Issued November 22, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22932
- Date
- November 22, 2019
- Company
- Seqirus Uk LimitedMaidenhead, Berkshire, United Kingdom
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUCELVAX QUAD | 02494256 | Approved |
| FLUCELVAX QUAD | 02494248 | Dormant |
Medicinal ingredients
- HAEMAGGLUTININ-STRAIN A(H1N1) 15 MCG per 0.5ML
- HAEMAGGLUTININ-STRAIN A(H3N2) 15 MCG per 0.5ML
- HAEMAGGLUTININ-STRAIN B(VICTORIA) 15 MCG per 0.5ML
- HAEMAGGLUTININ-STRAIN B(YAMAGATA) 15 MCG per 0.5ML
- HAEMAGGLUTININ-STRAIN A(H1N1) 15 MCG per SYR
- HAEMAGGLUTININ-STRAIN A(H3N2) 15 MCG per SYR
- HAEMAGGLUTININ-STRAIN B(VICTORIA) 15 MCG per SYR
- HAEMAGGLUTININ-STRAIN B(YAMAGATA) 15 MCG per SYR